ISSN: 0166-3542

Journal Home

Journal Guideline

Antiviral Research Q1 Unclaimed

Elsevier Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Antiviral Research is a journal indexed in SJR in Pharmacology and Virology with an H index of 144. It has an SJR impact factor of 1,701 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,701.

Antiviral Research focuses its scope in these topics and keywords: human, virus, hiv, vitro, treatment, antiviral, drug, effect, primary, activity, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Virology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,701

SJR Impact factor

144

H Index

147

Total Docs (Last Year)

558

Total Docs (3 years)

6959

Total Refs

3965

Total Cites (3 years)

557

Citable Docs (3 years)

8.27

Cites/Doc (2 years)

47.34

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

Interactions of the HIV fusion inhibitor AR177 (ZINTEVIR) with the HIV type I second receptor

The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet

Highly selective inhibitors of terminal deoxynucleotidyl transferase in cell free systems

Combination of antiviral with anti-inflammatory preparations for the topical treatment for recurrent herpes simplex assessed using a zosteriform murine infection model

Cidofovir: Induction of apoptosis in human papilloma virus (HPV)-containing cell lines

Enzymatic synthesis of 3'-azido-3'-deoxy-5'-O-(1,2-dihexadecanoyl-3-sn-phosphatidyl)thymidine involving commercially available phospholipase D type VII

Inhibition of HPV-11 gene expression with chimeric methylphosphonate oligomers

High throughput screening for small molecule inhibitors of the HIV- Rev-RRE interaction

Small-sized HIV protease inhibitors containing allophenyinorstatine exhibit antiviral activities

Cellular zinc status regulates cytomegalovirus major immediate-early promoter

Cartesian coordinate analysis of viral burden and CD4 + cell count in HIV disease: implications for clinical trial design and analysis

Synthesis and in vitro antiviral activity of long-chain 5'-O-alkoxycarbonylphosphinyl)-3'-azido-3'-deoxythymidines against drug-sensitive and AZT- or PFA-resistant human immunodeficiency virus type-1 (HIV-1)

SHOW MORE ARTICLES

Phosphoramidate derivatives of d4T as inhibitors of HIV: The effect of amino acid variation

Herpes zoster: focus on treatment in older adults

Pharmacokinetics and distribution of penciclovir to the brain and muscle in the rat studied by microdialysis

Synthesis, anti-human immunodeficiency virus activities, cytotoxicities, and decomposition pathways of the bis(SATE)phosphotriester derivatives of AZT

Interspecies scale-up of antiviral nucleoside pharmacokinetics

Natural interferon- a treatment in chronic hepatitis B(HB) with pre-core stop codon mutation

Evaluation of long-term treatment with glycyrrhizin and of combination therapy with glycyrrhizin and AZT or DDI on HIV-1 carriers

[AZT]-[TSAO-T] and [AZT]-[HEPT] heterodimers as potential bi-functional inhibitors of HIV-1 reverse transcriptase, synthesis, structural assignment and Anti-HIV activity

Inhibition of arenavirus multiplication in vitro by phenotiazines

Index

Dose- and treatment duration-dependence of ganciclovir against murine cytomegalovirus infection in severe combined immunodeficient mice - experimental and clinical implications

Differential antiviral activity of several IMP dehydrogenase inhibitors